Grants paid by Dr Ralph & Marian Falk Medical Research TR
EIN 36-6975534 · Dallas, RI · Form 990-PF, Part XV
Dr Ralph & Marian Falk Medical Research TR of Dallas, RI (EIN 36-6975534) reported 143 grants paid totaling $46,409,104 to 40 recipients in tax years 2020–2025, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$46,409,104
143 grants
Recipients
40
distinct organizations
Tax years
2020–2025
6 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 1 | $6,977,935 | — |
| 2021 | 1 | $6,905,713 | — |
| 2022 | 20 | $8,399,800 | — |
| 2023 | 46 | $8,040,793 | — |
| 2024 | 37 | $7,805,072 | — |
| 2025 | 38 | $8,279,791 | — |
Top recipients
The 40 recipients receiving the most from Dr Ralph & Marian Falk Medical Research TR, by grants paid, out of 40 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| See Attached See Attached | U | See Attached, RI | 2 | $13,883,648 | 2021 |
| Medical College of Wisconsin 39-0806261 | C | Milwaukee, WI | 7 | $2,946,969 | 2025 |
| Yale University School of Medicine | U | New Haven, CT | 9 | $2,517,944 | 2025 |
| Cleveland Clinic Foundation 91-2153073 | C | Cleveland, OH | 8 | $2,514,767 | 2025 |
| Childrens Hospital Medical Center 31-0833936 | B | Cincinnati, OH | 6 | $1,983,769 | 2025 |
| Case Western Reserve University | U | Cleveland, OH | 8 | $1,878,494 | 2025 |
| Indiana University 20-2804389 | C | Bloomington, IN | 8 | $1,643,505 | 2025 |
| Brown University of Providence 9998 05-0258809 | D | Providence, RI | 6 | $1,583,096 | 2025 |
| University of Minnesota | U | Minneapolis, MN | 9 | $1,546,532 | 2025 |
| University of Cincinnati | U | Cleveland, OH | 6 | $1,370,293 | 2024 |
| Thomas Jefferson University 23-1352651 | B | Philadelphia, PA | 5 | $1,347,499 | 2025 |
| Northwestern University 36-2167817 | B | Evanstone, IL | 6 | $1,028,586 | 2025 |
| Board Regents of University of Wisconsin | U | Milwaukee, WI | 4 | $870,487 | 2025 |
| Regents of University of Michigan | U | Pittsburgh, PA | 1 | $869,930 | 2022 |
| Michigan State University | U | East Lansing, MI | 4 | $850,000 | 2025 |
| Regents of University of Michigan 38-6006309 | D | Ann Arbor, MI | 5 | $840,000 | 2025 |
| Ohio State University | U | Columbus, OH | 5 | $822,442 | 2025 |
| Stanford University 26-4580872 | B | Menlo Park, CA | 3 | $800,189 | 2024 |
| Mayo Clinic | U | Minneapolis, MN | 4 | $700,000 | 2025 |
| University of Chicago 36-2177139 | C | Chicago, IL | 4 | $692,060 | 2025 |
| Stanford University - Development Services | U | Redwood City, CA | 4 | $622,886 | 2023 |
| University of Chicago | U | Chicago, IL | 3 | $575,685 | 2024 |
| Universityof Minnesota | U | Minneapolis, MN | 2 | $543,983 | 2025 |
| Rehabilitation Institute of Chicago 36-2256036 | B | Chicago, IL | 3 | $525,091 | 2025 |
| Washington University 52-1538367 | B | St Louis, MO | 3 | $523,501 | 2025 |
| State University of Iowa 42-0796760 | D | Iowa City, IA | 2 | $343,223 | 2024 |
| Indiana University | U | Detroit, MI | 1 | $320,000 | 2022 |
| Rush University Medical Center 36-2174823 | C | Chicago, IL | 2 | $299,458 | 2023 |
| University of Iowa Research Foundation 23-7436761 | B | Iowa City, IA | 2 | $294,489 | 2023 |
| Purdue University 52-1276063 | B | West Lafayette, IN | 1 | $257,044 | 2025 |
| University of Iowa | U | Iowa City, IA | 1 | $208,319 | 2025 |
| Kumc Ri | U | Kansas City, KS | 1 | $200,000 | 2022 |
| Regents of the Univ of Minnesota | U | Minneapolis, MN | 1 | $200,000 | 2022 |
| Washington University 43-0653611 | C | St Louis, MO | 1 | $175,216 | 2024 |
| Loyola University of Chicago 36-1408475 | B | Chicago, IL | 1 | $175,000 | 2025 |
| University of Cincinnati 51-0254963 | B | Cleveland, OH | 1 | $175,000 | 2025 |
| Kumc Research Institute 48-1108830 | B | Kansas City, KS | 1 | $100,000 | 2023 |
| Board of Trustees U of Illinois | U | Chicago, IL | 1 | $60,000 | 2022 |
| University of Cincinnati | U | Cleveland, ND | 1 | $60,000 | 2022 |
| Board Regents of U of Wisconsin | U | Milwaukee, WI | 1 | $59,999 | 2022 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 143 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Case Western Reserve University Cleveland, OH | U | $355,809 | paid | IMMUNOTHERAPY FOR B CELL | 202600389349100700 |
| 2025 | Yale University - School of Medicine New Haven, CT | U | $348,252 | paid | MAKING CANCER CELLS LOOK | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $340,879 | paid | PIM2 MODULATOR-MULTIPLE | 202600389349100700 |
| 2025 | Medical College of Wisconsin Milwaukee, WI | B | $334,583 | paid | PAIN THERAPY - SENSORY | 202600389349100700 |
| 2025 | Thomas Jefferson University Philadelphia, PA | B | $333,333 | paid | PROTACS FOR TARGETING BRCA | 202600389349100700 |
| 2025 | Cleveland Clinic Foundation Cleveland, OH | C | $331,873 | paid | DEVELOPMENT OF NEW DRUG FOR | 202600389349100700 |
| 2025 | Board Regents of University of Wisconsin Milwaukee, WI | U | $330,487 | paid | IMPROVE DIAGNOSIS OF BREAST | 202600389349100700 |
| 2025 | Medical College of Wisconsin Milwaukee, WI | B | $315,981 | paid | NEW DRUGS TO TREAT | 202600389349100700 |
| 2025 | Universityof Minnesota Minneapolis, MN | U | $308,897 | paid | T3 THERAPY - HEART FAILURE | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $284,681 | paid | OPTIMIZED MECHANISM BASED | 202600389349100700 |
| 2025 | University of Chicago Chicago, IL | C | $268,735 | paid | METASTIC LUNG CANCER PHASE | 202600389349100700 |
| 2025 | Purdue University West Lafayette, IN | B | $257,044 | paid | ADVANCING MICRO RNAS AS | 202600389349100700 |
| 2025 | Northwestern University Evanston, IL | B | $210,398 | paid | THERAPY FOR CHRONIC KIDNEY | 202600389349100700 |
| 2025 | University of Iowa Iowa City, IA | U | $208,319 | paid | VASCULAR HEALTH TARGETING | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $203,837 | paid | SYSTEMIC BACTEREMIA - HOST | 202600389349100700 |
| 2025 | Cleveland Clinic Foundation Cleveland, OH | C | $186,955 | paid | TREATMENT OF COMPLEX | 202600389349100700 |
| 2025 | Ohio State University Columbus, OH | U | $178,604 | paid | MELANOMA ONSET & RECURRENCE | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $176,327 | paid | DEVELOP IL-15 - MALARIA | 202600389349100700 |
| 2025 | Shirley Ryan Ability Lab Chicago, IL | B | $175,864 | paid | RESTORE DIAPHRAGM - NERVE | 202600389349100700 |
| 2025 | Mayo Clinic Rochester, MN | U | $175,575 | paid | CD-19 TARGETED CAR-MSC19 IN | 202600389349100700 |
| 2025 | Michigan State University East Lansing, MI | U | $175,000 | paid | DEVELOP NEW ODC INHIBITORS | 202600389349100700 |
| 2025 | Loyola University of Chicago Chicago, IL | B | $175,000 | paid | INHIBITORS FOR TRIPLE | 202600389349100700 |
| 2025 | University of Cincinnati Cleveland, OH | B | $175,000 | paid | DEVELOP IMPROVED METHOD OF | 202600389349100700 |
| 2025 | Washington University St Louis, MO | B | $175,000 | paid | STEM CELL DERIVED ISLETS | 202600389349100700 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | $175,000 | paid | ANTIBODY CNS DELIVERY AND | 202600389349100700 |
| 2025 | Brown University of Providence Providence, RI | C | $175,000 | paid | REPURPOSING CLOPIDOGREL TO | 202600389349100700 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | $175,000 | paid | NEURO-CARDIAC MECHANISMS OF | 202600389349100700 |
| 2025 | Case Western Reserve University Cleveland, OH | U | $175,000 | paid | PHARMA STRATEGY TO TREAT | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $173,839 | paid | SOUND WAVES ASSESSMENT VIA | 202600389349100700 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $173,769 | paid | AUTOIMMUNE ARTHRITIS | 202600389349100700 |
| 2025 | Washington University St Louis, MO | B | $173,717 | paid | VAGUS NERVE STIMULATION - | 202600389349100700 |
| 2025 | Brown University of Providence Providence, RI | C | $173,096 | paid | GENE THERAPY FOR | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $169,910 | paid | TRAUMATIC BRAIN INJURY | 202600389349100700 |
| 2025 | Northwestern University Evanston, IL | B | $168,188 | paid | ANTIBODIES TREATMENT OF | 202600389349100700 |
| 2025 | Yale University - School of Medicine New Haven, CT | U | $161,487 | paid | ANTI VB2 ANTIBODY DRUG FOR | 202600389349100700 |
| 2025 | Ohio State University Columbus, OH | U | $151,908 | paid | DEVELOP NEW THERAPY FOR | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $150,426 | paid | SEVERITY MEASURE- ADDUCTOR | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $57,018 | paid | INHIBITORS-PEANUT SPECIFIC | 202600389349100700 |
| 2024 | University of Cincinnati Cleveland, OH | U | $497,018 | paid | INHIBITORS TARGETING PEANUT | 202540939349101804 |
| 2024 | Brown University of Providence Providence, RI | B | $495,146 | paid | ANTI-MALARIA DRUGS TARGETNG | 202540939349101804 |
| 2024 | Medical College of Wisconsin Milwaukee, WI | B | $377,004 | paid | NEW DRUGS TO TREAT | 202540939349101804 |
| 2024 | Case Western Reserve University Cleveland, OH | U | $343,159 | paid | B CELL CANCER THERAPY USING | 202540939349101804 |
| 2024 | Cleveland Clinic Foundation Cleveland, OH | C | $336,255 | paid | DEVELOPMENT OF NEW DRUG FOR | 202540939349101804 |
| 2024 | Thomas Jefferson University Philadelphia, PA | B | $333,333 | paid | PROTACS FOR TARGETING BRCA | 202540939349101804 |
| 2024 | Medical College of Wisconsin Milwaukee, WI | B | $318,948 | paid | DEVELOPMENT OF SENSORY | 202540939349101804 |
| 2024 | Universityof Minnesota Minneapolis, MN | U | $235,086 | paid | THYROID HORMONE | 202540939349101804 |
| 2024 | University of Chicago Chicago, IL | U | $200,685 | paid | TUMOR ANUEPLOIDY - | 202540939349101804 |
| 2024 | Ohio State University Columbus, OH | U | $197,879 | paid | DEVELOP NEW THERAPY FOR | 202540939349101804 |
| 2024 | Regents of University of Michigan Ann Arbor, MI | D | $190,000 | paid | DEVICE TO PREDICT | 202540939349101804 |
| 2024 | Childrens Hospital Medical Center Cincinnati, OH | B | $190,000 | paid | LUPUS NEPHRITIS BIOMARKERS | 202540939349101804 |
| 2024 | Cleveland Clinic Foundation Cleveland, OH | C | $190,000 | paid | NEW WEAPONS TO FIGHT | 202540939349101804 |
| 2024 | Yale University School of Medicine New Haven, CT | U | $190,000 | paid | TARGETED DEGREDATION OF | 202540939349101804 |
| 2024 | State University of Iowa Iowa City, IA | D | $187,210 | paid | IMPROVE HYPOXIC TUMOR MGMT | 202540939349101804 |
| 2024 | Mayo Clinic Rochester, MN | U | $181,905 | paid | IN VIVO GENERATION OF CAR T | 202540939349101804 |
| 2024 | Indiana University Bloomington, IN | C | $179,775 | paid | TRAUMATIC BRAIN INJURY | 202540939349101804 |
| 2024 | Rehabilitation Institute of Chicago Chicago, IL | B | $177,796 | paid | REPURPOSE 5-AZACYTIDINE - | 202540939349101804 |
| 2024 | Indiana University Bloomington, IN | C | $177,271 | paid | NOVEL MINIMALLY INVASIVE | 202540939349101804 |
| 2024 | Stanford University Stanford, CA | C | $176,215 | paid | METABOLIC PAUSING - ORGAN | 202540939349101804 |
| 2024 | Washington University St Louis, MO | C | $175,216 | paid | ZIKA VIRUS GENETIC ARMING- | 202540939349101804 |
| 2024 | Board Regents of University of Wisconsin Milwaukee, WI | U | $175,000 | paid | DIABETES STEM CELL CURE - | 202540939349101804 |
| 2024 | Brown University of Providence Providence, RI | B | $175,000 | paid | REPURPOSING CLOPIDOGREL TO | 202540939349101804 |
| 2024 | Case Western Reserve University Cleveland, OH | U | $175,000 | paid | BLOCKING PEPTIDE TREATMENT | 202540939349101804 |
| 2024 | University of Cincinnati Cleveland, OH | U | $175,000 | paid | DEVELOP IMPROVED METHOD OF | 202540939349101804 |
| 2024 | University of Chicago Chicago, IL | U | $175,000 | paid | DEVELOPMENT OF SYNGAP1 | 202540939349101804 |
| 2024 | Michigan State University East Lansing, MI | U | $175,000 | paid | DEVELOP NEW ODC INHIBITORS | 202540939349101804 |
| 2024 | Mayo Clinic Rochester, MN | U | $174,425 | paid | CD-19 TARGETED CAR-MSC19 IN | 202540939349101804 |
| 2024 | University of Minnesota Minneapolis, MN | U | $173,673 | paid | DEVELOP IL-15 - MALARIA | 202540939349101804 |
| 2024 | Yale University School of Medicine New Haven, CT | U | $173,017 | paid | DEVELOP PHAGE THERAPY TO | 202540939349101804 |
| 2024 | University of Minnesota Minneapolis, MN | U | $168,835 | paid | SEVERITY MEASURE- ADDUCTOR | 202540939349101804 |
| 2024 | Stanford University Stanford, CA | C | $163,974 | paid | NOVEL DNA-GUIDED ARGONAUTE | 202540939349101804 |
| 2024 | Thomas Jefferson University Philadelphia, PA | B | $150,887 | paid | CHEMOKINE ANTAGONIST FOR | 202540939349101804 |
| 2024 | University of Cincinnati Cleveland, OH | U | $145,339 | paid | TARGETING SEXUAL CYCLE OF | 202540939349101804 |
| 2024 | University of Cincinnati Cleveland, OH | U | $136,995 | paid | LETROZOLE- NOVEL | 202540939349101804 |
| 2024 | Indiana University Bloomington, IN | C | $100,000 | paid | NOVEL RXR AGONIST FOR | 202540939349101804 |
| 2024 | Northwestern University Evanston, IL | B | $18,026 | paid | T CELL THERAPY FOR | 202540939349101804 |
| 2023 | Brown University of Providence Providence, RI | C | $504,854 | paid | ANTI-MALARIA DRUGS TARGETNG | 202410899349100531 |
| 2023 | Indiana University Bloomington, IN | C | $445,923 | paid | TARGETING PEANUT-SPECIFIC | 202410899349100531 |
| 2023 | Medical College of Wisconsin Sen Neuron Milwaukee, WI | C | $346,469 | paid | DEVELOPMENT OF SENSORY | 202410899349100531 |
| 2023 | Thomas Jefferson University Philadelphia, PA | B | $333,333 | paid | PROTACS FOR TARGETING BRCA | 202410899349100531 |
| 2023 | Northwestern University Evanstone, IL | B | $331,974 | paid | T CELL THEARPY FOR | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $301,032 | paid | B CELL CANCER THERAPY USING | 202410899349100531 |
| 2023 | University of Cincinnati Cleveland, OH | U | $211,322 | paid | STUDIES FOR REPURPOSING | 202410899349100531 |
| 2023 | University of Cincinnati Cleveland, OH | U | $204,619 | paid | TARGETING SEXUAL CYCLE OF | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $200,000 | paid | LUPUS NEPHRITIS BIOMARKERS | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $200,000 | paid | TARGETED DEGREDATION OF | 202410899349100531 |
| 2023 | Regents of University of Michigan Ann Arbor, MI | D | $200,000 | paid | DEVICE TO PREDICT | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $200,000 | paid | NEW WEAPONS TO FIGHT | 202410899349100531 |
| 2023 | Thomas Jefferson University Philadelphia, PA | B | $196,613 | paid | CHEMOKINE ANTAGONIST FOR | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $190,000 | paid | DEVELOP HUMAN LIVER | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $190,000 | paid | NOVEL THERAPIES - MAJOR | 202410899349100531 |
| 2023 | Board Regents of University of Wisconsin Milwaukee, WI | U | $190,000 | paid | NANOPARTICLES TARGET | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $175,188 | paid | DEVELOP PHAGE THERAPY TO | 202410899349100531 |
| 2023 | Board Regents of University of Wisconsin Milwaukee, WI | U | $175,000 | paid | DIABETES STEM CELL CURE - | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $175,000 | paid | DEVELOPMENT OF SYNGAP1 | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $175,000 | paid | BLOCKING PEPTIDE TREATMENT | 202410899349100531 |
| 2023 | Washington University St Louis, MO | B | $174,784 | paid | ZIKA VIRUS GENETIC ARMING- | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $173,785 | paid | METABOLIC PAUSING - ORGAN | 202410899349100531 |
| 2023 | Indiana University Bloomington, IN | C | $172,729 | paid | NOVEL MINIMALLY INVASIVE | 202410899349100531 |
| 2023 | Rehabilitation Institute of Chicago Chicago, IL | B | $171,431 | paid | REPURPOSE 5-AZACYTIDINE - | 202410899349100531 |
| 2023 | Mayo Clinic Minneapolis, MN | U | $168,095 | paid | IN VIVO GENERATION - CAR T | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $159,101 | paid | NOVEL DNA-GUIDED ARGONAUTE | 202410899349100531 |
| 2023 | State University of Iowa Iowa City, IA | D | $156,013 | paid | IMPROVE HYPOXIC TUMOR MGMT | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $148,325 | paid | TUMOR ANUEPLOIDY - | 202410899349100531 |
| 2023 | University of Minnesota Minneapolis, MN | U | $114,914 | paid | AEROSOLIZED THYROID HORMONE | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $100,000 | paid | BEDSIDE LIQUID BIOPSY FOR | 202410899349100531 |
| 2023 | Kumc Research Institute Kansas City, KS | B | $100,000 | paid | EULICIDATING ROLES RELATED | 202410899349100531 |
| 2023 | University of Minnesota Minneapolis, MN | U | $100,000 | paid | ELECTRICAL BRAIN CIRCUIT | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $100,000 | paid | BIOMARKERS FOR IMMUNE | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $100,000 | paid | DEVELOP ANTIGEN-MIMICRY | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $100,000 | paid | STATISTICAL DESIGN OF | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $100,000 | paid | GLIOBLASTOMA ANTI-CANCER | 202410899349100531 |
| 2023 | Michigan State University East Lansing, MI | U | $100,000 | paid | MMPL3 INHIBITORS - | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $100,000 | paid | EARLY OUTCOME INDICATORS | 202410899349100531 |
| 2023 | Northwestern University Evanstone, IL | B | $100,000 | paid | NEOANTIGEN INDUCERS AS | 202410899349100531 |
| 2023 | Regents of University of Michigan Ann Arbor, MI | D | $100,000 | paid | DECODING THE DRUGGABLE | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $99,684 | paid | DEVELOPMENT OF NEW DRUG FOR | 202410899349100531 |
| 2023 | Rush University Medical Center Chicago, IL | B | $99,458 | paid | ANTI-HIV ANTIBODIES TO | 202410899349100531 |
| 2023 | University of Iowa Research Foundation Iowa City, IA | B | $94,489 | paid | PIEZOELECTRIC IMMUNOSENSOR | 202410899349100531 |
| 2023 | Ohio State University Columbus, OH | U | $94,051 | paid | OPTIMIZING BTK INHIBITOR | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $93,494 | paid | IMMUNOTHERAPY FOR B CELL | 202410899349100531 |
| 2023 | Medical College of Wisconsin Milwaukee, WI | B | $74,113 | paid | NEW DRUGS TO TREAT | 202410899349100531 |
| 2022 | Medical College of Wisconsin Milwaukee, WI | C | $1,179,871 | paid | RESEARCH FOR CHRONIC PAIN; | 202342439349101009 |
| 2022 | Childrens Hospital Medical Center Cincinnati, OH | B | $1,130,000 | paid | RESEARCH FOR PARKINSONS, | 202342439349101009 |
| 2022 | Cleveland Clinic Foundation Cleveland, OH | C | $1,070,000 | paid | GLIOBLASTOMA TREATMENTS & | 202342439349101009 |
| 2022 | Yale University School of Medicine New Haven, CT | U | $1,070,000 | paid | DEVELOPE CANCER VACCINES; | 202342439349101009 |
| 2022 | Regents of University of Michigan Pittsburgh, PA | U | $869,930 | paid | DEVICE TO PREDICT | 202342439349101009 |
| 2022 | Stanford University Menlo Park, CA | B | $460,000 | paid | BIOMARKERS FOR IMMUNE | 202342439349101009 |
| 2022 | Michigan State University East Lansing, MI | U | $400,000 | paid | NOVEL RXR AGONIST FOR | 202342439349101009 |
| 2022 | Indiana University Detroit, MI | U | $320,000 | paid | TARGETING PEANUT-SPECIFIC | 202342439349101009 |
| 2022 | Case Western Reserve University Cleveland, OH | U | $260,000 | paid | IMMUNOTHERAPY FOR B CELL | 202342439349101009 |
| 2022 | Kumc Ri Kansas City, KS | U | $200,000 | paid | EULICIDATING THE ROLE OF | 202342439349101009 |
| 2022 | Northwestern University Evanstone, IL | B | $200,000 | paid | NEOANTIGEN INDUCERS AS | 202342439349101009 |
| 2022 | Regents of the Univ of Minnesota Minneapolis, MN | U | $200,000 | paid | ELECTRICAL BRAIN CIRCUIT | 202342439349101009 |
| 2022 | Ohio State University Columbus, OH | U | $200,000 | paid | OPTIMIZINGN BTK INHIBITOR | 202342439349101009 |
| 2022 | University of Iowa Research Foundation Iowa City, IA | B | $200,000 | paid | PIEZOELECTRIC IMMUNOSENSOR | 202342439349101009 |
| 2022 | Rush University Medical Center Chicago, IL | C | $200,000 | paid | ANTI-HIV ANTIBODIES TO | 202342439349101009 |
| 2022 | University of Chicago Chicago, IL | U | $200,000 | paid | INSTATISTICAL DESIGN OF | 202342439349101009 |
| 2022 | University of Cincinnati Cleveland, ND | U | $60,000 | paid | HUMANIZED ANTIBODY | 202342439349101009 |
| 2022 | Brown University of Providence 9998 Providence, RI | D | $60,000 | paid | ANTI-MALARIA DRUGS TARGETNG | 202342439349101009 |
| 2022 | Board of Trustees U of Illinois Chicago, IL | U | $60,000 | paid | ALZHEIMERS DISEASE | 202342439349101009 |
| 2022 | Board Regents of U of Wisconsin Milwaukee, WI | U | $59,999 | paid | IMMUNOTHERAPY TRIPLE | 202342439349101009 |
| 2021 | See Attached See Attached See Attached, RI | U | $6,905,713 | paid | UNRESTRICTED GENERAL | 202200909349100505 |
| 2020 | See Attached See Attached See Attached, RI | U | $6,977,935 | paid | UNRESTRICTED GENERAL | 202120219349100612 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2025 | 2025-11-30 | not stated | 2024v5.2 | 202600389349100700 |
| 990PF | 2024 | 2024-11-30 | not stated | 2023v6.0 | 202540939349101804 |
| 990PF | 2023 | 2023-11-30 | not stated | 2022v5.0 | 202410899349100531 |
| 990PF | 2022 | 2022-11-30 | not stated | 2021v4.1 | 202342439349101009 |
| 990PF | 2021 | 2021-11-30 | not stated | 2020v4.1 | 202200909349100505 |
| 990PF | 2020 | 2020-11-30 | not stated | 2019v5.0 | 202120219349100612 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/366975534.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.